Allspring Global Investments Holdings LLC Trims Position in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Allspring Global Investments Holdings LLC lessened its holdings in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 10.4% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 284,547 shares of the company's stock after selling 33,161 shares during the quarter. Allspring Global Investments Holdings LLC owned approximately 0.45% of Guardian Pharmacy Services worth $6,049,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. BNP Paribas Financial Markets bought a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $37,000. JPMorgan Chase & Co. bought a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $77,000. Quantbot Technologies LP bought a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $81,000. Corebridge Financial Inc. bought a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $87,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $98,000.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Raymond James Financial set a $28.00 price target on shares of Guardian Pharmacy Services and gave the stock an "outperform" rating in a report on Wednesday, May 14th. Wall Street Zen lowered shares of Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Truist Financial reaffirmed a "buy" rating and set a $28.00 price objective (up previously from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th.

Insiders Place Their Bets

In related news, Director John Ackerman sold 201,303 shares of Guardian Pharmacy Services stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $4,058,268.48. Following the completion of the sale, the director owned 149,794 shares of the company's stock, valued at approximately $3,019,847.04. This trade represents a 57.34% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director William E. Bindley sold 651,454 shares of Guardian Pharmacy Services stock in a transaction on Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total transaction of $13,133,312.64. Following the completion of the sale, the director directly owned 1,939,817 shares of the company's stock, valued at approximately $39,106,710.72. The trade was a 25.14% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,344,912 shares of company stock worth $228,713,426 in the last quarter. Insiders own 63.71% of the company's stock.

Guardian Pharmacy Services Stock Performance

Shares of GRDN stock traded up $0.19 during trading hours on Wednesday, hitting $21.14. 199,039 shares of the company were exchanged, compared to its average volume of 185,885. Guardian Pharmacy Services, Inc. has a fifty-two week low of $14.16 and a fifty-two week high of $26.91. The company has a 50 day simple moving average of $22.16 and a two-hundred day simple moving average of $21.49.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings results on Monday, May 12th. The company reported $0.21 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $329.31 million for the quarter, compared to analyst estimates of $321.21 million. On average, equities analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.